#
Sodium Nitroprusside Injection Concentrate
  • Professionals
  • FDA PI

Sodium Nitroprusside Injection Concentrate

Dosage form: injection, solution, concentrate
Drug classes:Agents for hypertensive emergencies, Vasodilators

Medically reviewed by Drugs.com. Last updated on Feb 1, 2021.

Sodium Nitroprusside Injectionis not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion.

Sodium Nitroprusside Injectioncan cause precipitous decreases in blood pressure (seeDOSAGE AND ADMINISTRATION). In patients not properly monitored, these decreases can lead to irreversible ischemic injuries or death. Sodium nitroprusside should be used only when available equipment and personnel allow blood pressure to be continuously monitored.

Except when used briefly or at low (< 2 mcg/kg/min) infusion rates, sodium nitroprusside gives rise to important quantities of cyanide ion, which can reach toxic, potentially lethal levels (seeWARNINGS). The usual dose rate is 0.5 to 10 mcg/kg/min, but infusion at the maximum dose rate should never last more than 10 minutes. If blood pressure has not been adequately controlled after 10 minutes of infusion at the maximum rate, administration of sodium nitroprusside should be terminated immediately.

Although acid-base balance and venous oxygen concentration should be monitored and may indicate cyanide toxicity, these laboratory tests provide imperfect guidance.

DESCRIPTION

Sodium nitroprusside is disodium pentacyanonitrosylferrate(2-) dihydrate, a hypotensive agent whose structural formula is


Sodium Nitroprusside

whose molecular formula is Na2[Fe(CN)5NO] • 2H2O, and whose molecular weight is 297.95. Dry sodium nitroprusside is a reddish-brown crystals or powder, freely soluble in water. In an aqueous solution infused intravenously, sodium nitroprusside is a rapid-acting vasodilator, active on both arteries and veins.

Sodium nitroprusside solution is rapidly degraded by trace contaminants,..